MoonLake Immunotherapeutics Cash And Cash Equivalents At Carrying Value

Quick Answer

MoonLake Immunotherapeutics reported Cash And Cash Equivalents At Carrying Value of $334.52 million for the year ending 2025.

  • MoonLake Immunotherapeutics showed an increase of +85.4% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from MoonLake Immunotherapeutics's annual report (Form 10-K), filed with the SEC on February 25, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), MoonLake Immunotherapeutics's Cash And Cash Equivalents At Carrying Value has grown by 24,940.1%.
  • Historical annual values: Fiscal year 2025: $334.52 million | Fiscal year 2024: $180.43 million | Fiscal year 2023: $451.17 million | Fiscal year 2022: $39.51 million | Fiscal year 2021: $8.04 million | Fiscal year 2020: $1.34 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: